Skilled in the Art With Scott Graham: In Defense of Patent Thickets + Gaming Out a Year of Section 101 Limbo + Bad Takes From a PTAB Reform Hearing
Hughes Hubbard life sciences chief Patrice Jean says that, given the complexity that goes into some pharmaceuticals, it's "understandable that you would have dozens of patents that potentially cover what the outcome is."
June 24, 2022 at 02:44 PM
14 minute read
Skilled in the Art
Welcome to Skilled in the Art. I'm Law.com IP reporter Scott Graham. Here's what's cracking this week:
• Senators are on the warpath about patent thickets and continuations, but one patent counselor says to chill.
• Gaming out a year of Section 101 limbo if the Supreme Court takes American Axle on Monday.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 2First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4The Growing Tension—And Opportunity—in Big Law Nonequity Tiers
- 5The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
